Perspectives

In short, the mid-decade redistricting exacerbated by Callais backfired in the 2026 midterm elections but that does not take away from Callais’s doctrinal damage or its potential consequences in the mid-to-long term, writes Travis Crum.

Lan Yang, professor at Washington University in St. Louis and co-founder of DeepSight Technology, shares her experience of pursuing meaningful results in different ways.

Whether in the laboratory, classroom or community, the ability to bring people together around a shared purpose is a skill that can amplify your impact long after the conversation ends, writes Nicoletta Memos.

Menopause offers an opportunity to ask about the skeleton while a person still feels well. The answer may involve a risk assessment, suitable activity, nutritional changes or medical treatment. A bone health conversation can begin long before a fracture starts it, writes Priya Bhardwaj.

Thinking back to my own childhood, I can pinpoint how my academic interests were fostered through museums, whether gazing up at galaxies at the Hayden Planetarium or sleeping under the belly of the blue whale in the Hall of Ocean Life, writes graduate student Lili Mei Granda Argianas.

While affordability pressures are hitting Americans in many facets of their lives, from groceries to gas prices to housing costs, one important expense often gets less attention – childcare, writes Caitlyn Collins.

I still cherish the tactile quality of scribbling and scrawling my way through a lecture—the slow reveal of important concepts, the ease of annotating images, even the pen-stained hands, writes Eric Fournier.

Author and illustrator John Hendrix, at the Sam Fox School, has published a book designed for kids that encourages creativity and finding joy in making art.

WashU’s Ian Bogost, author most recently of “The Small Stuff,” chats with the “Life, Automated” podcast about how modern technology can optimize away “the sensory enchantment of everyday life.”

Through new categorical drug exclusions and a manufacturer-level exemption for companies participating in GENEROUS, CMS has narrowed GLOBE to an estimated 3 percent of eligible Part B drug spending and four or perhaps even fewer manufacturers, writes Rachel Sachs.